Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00314665 · ClinicalTrials.gov registry record · Phase 4
Use of Thalidomide in Chronic Uveitis
A Phase 4 study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT00314665 is a Phase 4 study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 15 participants.
The verdict
NCT00314665, a Phase 4 study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
This research study is for patients that have been diagnosed with chronic uveitis, a disease that causes inflammation in the eye. Patients are currently being treated with Remicade, Humira, Methotrexate and or similar chemotherapy type drugs to control this inflammation. Despite these medications, patients still have inflammation in their eyes. Patients are being asked to add an additional drug, thalidomide.
Interventions
- DRUG Thalidomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00314665
The ClinicalTrials.gov registry entry for NCT00314665 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thalidomide is the first listed.
NCT00314665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00314665 about?
NCT00314665 is a clinical study titled "Use of Thalidomide in Chronic Uveitis". This research study is for patients that have been diagnosed with chronic uveitis, a disease that causes inflammation in the eye. Patients are currently being treated with Remicade, Humira, Methotrexate and or similar chemotherapy type drugs to control this inflammation. Despite these medications, p...
What is the current status of trial NCT00314665?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2004-01. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00314665?
The interventions under investigation include: Thalidomide (DRUG).
Who is sponsoring clinical trial NCT00314665?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.